We are live on
!
Find out more
WCM
Washington Capital Management Portfolio holdings
AUM
$152M
1-Year Est. Return
30.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.39%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.9%
5 Year Est. Return
+81.36%
10 Year Est. Return
+354.14%
AUM
$99.3M
AUM Growth
-$4.72M
(-4.5%)
Cap. Flow
+$3.44M
Cap. Flow
% of AUM
3.46%
Top 10 Holdings %
Top 10 Hldgs %
42%
Holding
117
New
17
Increased
18
Reduced
30
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITT
ITT
|
+$972K |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$934K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$864K |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$846K |
| 5 |
Okta
OKTA
|
+$568K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.66M |
| 2 |
Pan American Silver
PAAS
|
+$956K |
| 3 |
Mercury Systems
MRCY
|
+$618K |
| 4 |
Omnicom Group
OMC
|
+$528K |
| 5 |
Lamb Weston
LW
|
+$500K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.02% |
| 2 | Industrials | 11.13% |
| 3 | Healthcare | 11.13% |
| 4 | Technology | 9.09% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Allison Transmission
ALSN
$10.2B
| $949K | 0.96% |
28,120
-400
| -1% | -$15K |
|
27
Bank of America
BAC
$416B
| $933K | 0.94% |
30,880
-1,095
| -3% | -$36.6K |
|
28
Cisco
CSCO
$434B
| $927K | 0.93% |
23,185
+255
| +1% | +$11.3K |
|
29
SLB Ltd
SLB
$79.1B
| $922K | 0.93% |
25,690
-450
| -2% | -$16.3K |
|
|
30
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.4B
| $910K | 0.92% |
+12,255
| New | +$934K |
|
31
ExxonMobil
XOM
$679B
| $897K | 0.9% |
10,270
-250
| -2% | -$22.8K |
|
32
Medtronic
MDT
$120B
| $884K | 0.89% |
10,950
+895
| +9% | +$80.4K |
|
33
IBM
IBM
$235B
| $882K | 0.89% |
7,425
-145
| -2% | -$19K |
|
|
34
ITT
ITT
$17.8B
| $871K | 0.88% |
+13,325
| New | +$972K |
|
35
Vanguard FTSE All-World ex-US ETF
VEU
$69.4B
| $833K | 0.84% |
18,775
-350
| -2% | -$17.3K |
|
36
Albemarle
ALB
$13.6B
| $770K | 0.78% |
2,910
-75
| -3% | -$19.1K |
|
|
FITB
37
Fifth Third Bancorp
FITB
$49.3B
| $751K | 0.76% |
23,500
| – | – |
|
38
BioMarin Pharmaceuticals
BMRN
$12.9B
| $695K | 0.7% |
8,200
| – | – |
|
39
Neurocrine Biosciences
NBIX
$16B
| $690K | 0.7% |
6,500
| – | – |
|
40
Verizon
VZ
$213B
| $677K | 0.68% |
17,830
-6,431
| -27% | -$286K |
|
41
Duke Energy
DUK
$92.8B
| $672K | 0.68% |
7,220
-140
| -2% | -$15K |
|
42
Campbell Soup
CPB
$6.34B
| $592K | 0.6% |
12,560
| – | – |
|
43
Cummins
CMI
$74.5B
| $590K | 0.59% |
2,900
| – | – |
|
44
BWX Technologies
BWXT
$13.6B
| $589K | 0.59% |
11,700
| – | – |
|
45
AT&T
T
$182B
| $589K | 0.59% |
38,373
-700
| -2% | -$12.7K |
|
46
GSK
GSK
$100B
| $585K | 0.59% |
19,869
+4,749
| +31% | +$180K |
|
47
ConocoPhillips
COP
$164B
| $563K | 0.57% |
5,500
| – | – |
|
48
Pinterest
PINS
$11.2B
| $557K | 0.56% |
23,900
| – | – |
|
49
Take-Two Interactive
TTWO
$41.7B
| $556K | 0.56% |
5,100
| – | – |
|
50
Booz Allen Hamilton
BAH
$9.52B
| $545K | 0.55% |
5,900
-1,500
| -20% | -$142K |
|
Similar funds
TC
TLC
MCAV
RAS
AL
PP
MWM
WN
Washington Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Washington Capital Management held 117 positions worth $99.3M, down 4.5% from $104M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Washington Capital Management deployed $3.44M of net new capital in Q3 2022, opening 17 new positions and adding to 18 existing holdings. Its largest new stake was ITT: 13,325 shares worth $871K.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 37% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.66M trimmed.
- Washington Capital Management's largest Q3 2022 buy was ITT: 13,325 shares worth $871K.
- Washington Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $864K increase.
- Washington Capital Management's biggest Q3 2022 reduction was Bristol-Myers Squibb, cutting an estimated $1.66M.
- Washington Capital Management fully exited Mercury Systems in Q3 2022, selling an estimated $618K.
- Washington Capital Management's ten largest holdings make up 42% of its $99.3M portfolio in Q3 2022.
- Washington Capital Management opened 17 new positions and closed 12 in Q3 2022.
- Washington Capital Management's portfolio value fell 4.5% quarter-over-quarter to $99.3M.
Based on Washington Capital Management's 13F filing for Q3 2022, filed 18 Oct 2022.